Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Tabares

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical and Experimental Medicine|February 24, 2023
STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failureAntonio Giovanni Solimando, Vanessa Desantis, Carmen Palumbo, et al.
Blood Advances|December 3, 2021
Junctional adhesion molecule C expression specifies a CD138low/neg multiple myeloma cell population in mice and humansAndreas Brandl, Antonio G Solimando, Zeinab Mokhtari, et al.
Leukemia|September 29, 2021
Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progressionJulia Dahlhoff, Hannah Manz, Tim Steinfatt, et al.
British Journal of Haematology|May 18, 2022
Minimal residual disease and imaging-guided consolidation strategies in newly diagnosed and relapsed refractory multiple myelomaDavid Böckle, Paula Tabares, Xiang Zhou, et al.
Frontiers in Immunology|February 15, 2021
A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host DiseaseCarina A Bäuerlein, Musga Qureischi, Zeinab Mokhtari, et al.
Blood Neoplasia|January 2, 2026
Bone marrow immune cell composition reflects multiple myeloma progression and affects treatment responseAnna Maria Corsale, Mojtaba Shekarkar Azgomi, Emilia Gigliotta, et al.
Haematologica|May 2, 2020
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progressionAntonio G Solimando, Matteo C Da Vià, Patrizia Leone, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical and Experimental Medicine|February 24, 2023
STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failureAntonio Giovanni Solimando, Vanessa Desantis, Carmen Palumbo, et al.
Blood Advances|December 3, 2021
Junctional adhesion molecule C expression specifies a CD138low/neg multiple myeloma cell population in mice and humansAndreas Brandl, Antonio G Solimando, Zeinab Mokhtari, et al.
Leukemia|September 29, 2021
Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progressionJulia Dahlhoff, Hannah Manz, Tim Steinfatt, et al.
British Journal of Haematology|May 18, 2022
Minimal residual disease and imaging-guided consolidation strategies in newly diagnosed and relapsed refractory multiple myelomaDavid Böckle, Paula Tabares, Xiang Zhou, et al.
Frontiers in Immunology|February 15, 2021
A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host DiseaseCarina A Bäuerlein, Musga Qureischi, Zeinab Mokhtari, et al.
Blood Neoplasia|January 2, 2026
Bone marrow immune cell composition reflects multiple myeloma progression and affects treatment responseAnna Maria Corsale, Mojtaba Shekarkar Azgomi, Emilia Gigliotta, et al.
Haematologica|May 2, 2020
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progressionAntonio G Solimando, Matteo C Da Vià, Patrizia Leone, et al.
Pageof 2